Table 2.
Long-term observation of muscle strength and laboratory test results in the patient after autologous stem-cell transplantation
| 25 months after
presentation (8 m after ASCT) |
28 m | 36 m | 51 m | 64 m | 77 m | 92 m
(75 m after ASCT) |
|
| Body weight, kg | 45.0 | 45.0 | 47.0 | 47.0 | 49.0 | 49.0 | 50.0 |
| Grip strength, kg | |||||||
| Right | 17 | 21 | 18 | 21 | 23 | 24 | 22 |
| Left | 18 | 21 | 19 | 21 | 24 | 22 | 23 |
| MRC scale | |||||||
| Shoulder abduction | 3 | 4 | 4 | NT | 4 | 4 | 4 |
| Hip flexion | 2 | 2 | 2 | NT | 2 | 2 | 4 |
| Pulmonary function test | |||||||
| FVC, L | 2.19 | 2.42 | 2.39 | 2.53 | 2.51 | 2.53 | 2.56 |
| Ratio of FVC to predicted value, % | 84.6 | 93.6 | 92.3 | 98.8 | 98.0 | 100.8 | 102.0 |
| FEV1, L | 1.96 | 2.15 | 2.07 | 2.15 | 2.10 | 2.06 | 2.01 |
| CK, U/L | 159 | 200 | 188 | 176 | 219 | 193 | 208 |
| Creatinine, mg/dL | 0.38 | 0.38 | 0.35 | 0.38 | 0.46 | 0.46 | 0.47 |
ASCT: autologous stem-cell transplantation
MRC: Medical Research Council
FVC: forced vital capacity
FEV1: forced expiratory volume in one second
CK: creatine kinase
NT: not tested